Development of Anti-Cancer Therapy based on Tumor Tropism

来源 :第三届国际纳米药物大会 ChinaNanomedicine 2018 The 3rd International Con | 被引量 : 0次 | 上传用户:speedieke
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  There exist multiple biological and physical barriers that prevent accumulation of therapeutic agents in the cancer tissue,limiting therapeutic efficacy and causing therapy resistance.
其他文献
  Herein,poly(L-lactic acid)(PLLA)nanofibrous spongy microspheres(NFSMS),PLLA/polyethylene glycol(PEG)co-functionalized mesoporous silica nanoparticles(MSN),a
会议
  PEG particles composed with large molecular weight of PEG and prepared from smaller MS templates result in longer circulation time and can avoid non-specifi
会议
  Platinum drugs comprise of almost 50%of all currently used anticancer drugs[1].They are now widely used in the clinical therapy of various solid tumors,incl
会议
  We developed bacterial phosphatase-responsive polyphosphoester cross-linked nanogels,which were modified with mannosyl ligands,for targeted antibiotic deliv
会议
  The light-triggered cancer diagnosis and therapy is primarily limited by the low efficiency of UV and visible light in tissue penetration.We report an upcon
会议
  As a novel two-dimensional material,graphene has recently raised much attention in biomedical field.Taking the advantages of large specific surface area,mul
会议
  Immunotherapy has attracted tremendous attention in recent years to treat many challenging diseases including cancer.In our recent studies,we have tried to
会议
  Magnetic iron oxide nanoparticles are very promising in cancer therapy due to their unprecedented magnetic control and MR imaging capabilities.But the premi
会议
  Silica nanoparticles(SiNPs)are widely applied in food sciences,industry and biomedicine,which greatly increase the human exposure and potential health risk.
会议
  Cancer immunotherapy is offering great clinical advances,in some cases providing stunning clinical outcomes.CAR-T and checkpoint inhibitors have yielded gre
会议